NCT01128621View on ClinicalTrials.gov

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 23, 2009

Primary Completion Date

April 12, 2010

Study Completion Date

April 12, 2010

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

GSK1292263

Tablet

DRUG

GSK1292263 matching placebo

Tablet

DRUG

Sitagliptin

Tablet

Trial Locations (2)

33169

GSK Investigational Site, Miami

91910

GSK Investigational Site, Chula Vista

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01128621 - A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263 | Biotech Hunter | Biotech Hunter